Top norovirus genotypes
Top norovirus genotypes
Recently, the previously less common GII.17 genotype increased in frequency of detection. In some countries, GII.17 viruses are now more frequently detected than GII.4 viruses, which have for decades been the most common genotype detected globablly.
Detection of GII.17 and GII.4 genotypes by date
Detection of selected genotype by date
Previously in 2023, new variants of the GII.4 genotype increased in frequency of detection (including GII.4 San Francisco, GII.4 Wichita, and GII.4 Allegany). In 2024-2025, detection of these variants declined.
Distribution of GII.4 variants
GII.4 variant type detection by date
Genotype distribution (percent of total number of sequences)












Contributors
Centers for Disease Control, Atlanta, GA, USA
Jan Vinjé, Leslie Barclay, and Eddie Bartlett
CDC Foundation, Atlanta, GA, USA
Jennifer Cannon, Shane Embury, and Boris Relja
Norosurv.org Developers
Pieter Ideler, Back-end developer (Pi-dev); Thijs Van de Velde, Front-end developer; Bram Borremans, Dev-ops (Bulls-i); Jennifer Cannon, RShiny dashboard
Research Institute for Tropical Medicine, Manila, the Philippines
Joseph Bonifacio, Mary Ann Igoy, C. Eures Iyar Oasin, and Mayan Lumandas
University of Valencia, Valencia, Spain
Javier Buesa and Noemi Navarro-Lleó
Costa Rican Institute of Research and Education in Nutrition and Health (INCIENSA), La Unión, Cartago, Costa Rica
Francisco Javier Duarte Martínez, Mariel López
Rotavirus and Norovirus Regional Reference Laboratory, Oswaldo Cruz Institute, Fiocruz, Brazilian Ministry of Health, Brazil
Tulio M. Fumian
Christian Medical College, Vellore, India
Tintu Varghese and K. Maheswari
Children’s Healthcare of Atlanta, Atlanta, GA, USA
Mark D. Gonzalez
Centre for Infectious Disease Researchin Zambia, Lusaka, Zambia
Luiza Miyanda Hatyoka, Kennedy Chibesa, and Michelo Simuyandi
Institute of Environmental Science and Research, Porirua, New Zealand
Joanne Hewitt and Dawn Croucher
LabPLUS, Auckland, New Zealand
Gary McAucliffe and Terri Swager
Taiwan Centers for Disease Control, Taipei, Taiwan
Jih-Hui Lin and Shu-Chun Chiu
University of Pretoria, Pretoria, South Africa
Janet Mans
University of Antofagasta, Antofagasta, Chile
Christian Muñoz and Margarita Lay
California Department of Public Health, Richmond, California, USA
Chao-Yang Pan, Thalia Huynh, Tasha Padilla, Christine Morales, and Debra Wadford
Alberta Precision Laboratory, Edmonton, Alberta, Canada
Xiao-Li Pang and Kanti Pabbaraju
Leipzig University Hospital, Leipzig, Germany
Corinna Pietsch
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
Mustafiz Rahman and Mohammad Enayet Hossain
Osaka Institute of Public Health, Osaka, Japan
Naomi Sakon
Children’s Mercy Hospitals and Clinics, Kansas City, Missouri, USA
Rangaraj Selvarangan, Ferdaus Hassan, Dithi Banerjee, Chris Harrison, and Mary Moffat
Center of Excellence in Clinical Virology, Chulalongkorn University, Bangkok, Thailand
Sompong Vongpunsawad
Instituto de Investigacion Nutricional, Lima, Peru
Claudio Lanata, Ana Gil, and Alejandra Ingunza
University of New South Wales, Sydney, Australia
Peter White
Laboratorio Nacional de Salud, Guatemala City, Guatermala
Linda Mendoza
Laboratorio de Virus Gastrointestinales, Mexico City, Mexico
Fabian Gómez Santiago
Legacy contributors
Martin Chi-Wai Chan and Lin-yao Zhang, Chinese University of Hong Kong, Hong Kong, China
Filemon Bucardo, National Autonomous University of Nicaragua, León, Nicaragua
Leesa Bruggink, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
Hannah Browne and Kenny Nguyen, CDC and CDC Foundation, Atlanta, GA, USA